Literature DB >> 22581996

Calcium deficiency reduces circulating levels of FGF23.

María E Rodriguez-Ortiz1, Ignacio Lopez, Juan R Muñoz-Castañeda, Julio M Martinez-Moreno, Alan Peralta Ramírez, Carmen Pineda, Antonio Canalejo, Philippe Jaeger, Escolastico Aguilera-Tejero, Mariano Rodriguez, Arnold Felsenfeld, Yolanda Almaden.   

Abstract

Fibroblast growth factor (FGF) 23 inhibits calcitriol production, which could exacerbate calcium deficiency or hypocalcemia unless calcium itself modulates FGF23 in this setting. In Wistar rats with normal renal function fed a diet low in both calcium and vitamin D, the resulting hypocalcemia was associated with low FGF23 despite high parathyroid hormone (PTH) and high calcitriol levels. FGF23 correlated positively with calcium and negatively with PTH. Addition of high dietary phosphorus to this diet increased FGF23 except in rats with hypocalcemia despite high PTH levels. In parathyroidectomized rats, an increase in dietary calcium for 10 days increased serum calcium, with an associated increase in FGF23, decrease in calcitriol, and no change in phosphorus. Also in parathyroidectomized rats, FGF23 increased significantly 6 hours after administration of calcium gluconate. Taken together, these results suggest that hypocalcemia reduces the circulating concentrations of FGF23. This decrease in FGF23 could be a response to avoid a subsequent reduction in calcitriol, which could exacerbate hypocalcemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581996      PMCID: PMC3380648          DOI: 10.1681/ASN.2011101006

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  23 in total

1.  STUDIES ON THE MODE OF ACTION OF IRRADIATED ERGOSTEROL: IV. in Hypoparathyroidism.

Authors:  W Bauer; A Marble; D Claflin
Journal:  J Clin Invest       Date:  1932-01       Impact factor: 14.808

2.  Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.

Authors:  Takashi Shimada; Yuji Yamazaki; Motoo Takahashi; Hisashi Hasegawa; Itaru Urakawa; Takeshi Oshima; Kaori Ono; Makoto Kakitani; Kazuma Tomizuka; Toshiro Fujita; Seiji Fukumoto; Takeyoshi Yamashita
Journal:  Am J Physiol Renal Physiol       Date:  2005-07-05

3.  PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.

Authors:  Vardit Lavi-Moshayoff; Gilad Wasserman; Tomer Meir; Justin Silver; Tally Naveh-Many
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-04

4.  Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.

Authors:  Tijana Krajisnik; Hannes Olauson; Majd A I Mirza; Per Hellman; Göran Akerström; Gunnar Westin; Tobias E Larsson; Peyman Björklund
Journal:  Kidney Int       Date:  2010-08-04       Impact factor: 10.612

Review 5.  Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease.

Authors:  Anna L Zisman; Myles Wolf
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

6.  Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

Authors:  Shiguang Liu; Wen Tang; Jianping Zhou; Jason R Stubbs; Qiang Luo; Min Pi; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2006-04-05       Impact factor: 10.121

7.  The parathyroid is a target organ for FGF23 in rats.

Authors:  Iddo Z Ben-Dov; Hillel Galitzer; Vardit Lavi-Moshayoff; Regina Goetz; Makoto Kuro-o; Moosa Mohammadi; Roy Sirkis; Tally Naveh-Many; Justin Silver
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.

Authors:  H Galitzer; I Z Ben-Dov; Justin Silver; Tally Naveh-Many
Journal:  Kidney Int       Date:  2009-12-16       Impact factor: 10.612

9.  Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.

Authors:  Chiaki Kumata; Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Ai Nakazawa; Fumiko Kondo; Yoshiyuki Kadokura; Eriko Kinugasa; Tadao Akizawa
Journal:  Am J Nephrol       Date:  2010-01-06       Impact factor: 3.754

10.  Aluminum administration in the rat separately affects the osteoblast and bone mineralization.

Authors:  M Rodriguez; A J Felsenfeld; F Llach
Journal:  J Bone Miner Res       Date:  1990-01       Impact factor: 6.741

View more
  82 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 2.  Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.

Authors:  Makoto Kuro-o
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

3.  Lack of FGF23 response to acute changes in serum calcium and PTH in humans.

Authors:  Katherine Wesseling-Perry; Hejing Wang; Robert Elashoff; Barbara Gales; Harald Jüppner; Isidro B Salusky
Journal:  J Clin Endocrinol Metab       Date:  2014-07-25       Impact factor: 5.958

4.  Lanthanum carbonate stimulates bone formation in a rat model of renal insufficiency with low bone turnover.

Authors:  Toshio Fumoto; Masako Ito; Kyoji Ikeda
Journal:  J Bone Miner Metab       Date:  2013-10-15       Impact factor: 2.626

5.  Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial.

Authors:  Juan C Ramirez-Sandoval; Mauricio Arvizu-Hernandez; Cristino Cruz; Barbara Vazquez-Cantu; Luis J Rojas-Concha; Luis Tamez; Fagundo Reynerio; F Enrique Gomez; Ricardo Correa-Rotter
Journal:  J Nephrol       Date:  2019-03-19       Impact factor: 3.902

6.  Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?

Authors:  Pieter Evenepoel; Bjorn Meijers
Journal:  Nat Rev Nephrol       Date:  2012-10-09       Impact factor: 28.314

Review 7.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

8.  High calcium diet alleviates 5/6 nephrectomy-induced bone deteriorations of lumbar vertebrae in mice.

Authors:  Hai-Tao Hou; Ya-Nan Wang; Shi-Ze Shao; Song Fu; Xiang-Peng Huang; Xiao-Hui Wang
Journal:  Exp Ther Med       Date:  2018-02-14       Impact factor: 2.447

9.  Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.

Authors:  Dominique Kosk; Holly Kramer; Amy Luke; Pauline Camacho; Pascal Bovet; Jacob Plange Rhule; Terrence Forrester; Myles Wolf; Chris Sempos; Michal L Melamed; Lara R Dugas; Richard Cooper; Ramon Durazo-Arvizu
Journal:  J Bone Miner Metab       Date:  2016-12-09       Impact factor: 2.626

10.  Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.

Authors:  S M Bristow; G D Gamble; A Pasch; W C O'Neill; A Stewart; A M Horne; I R Reid
Journal:  Osteoporos Int       Date:  2015-10-22       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.